Effect of Anticoagulation Therapy on Clinical Outcomes in COVID-19
Condition(s):COVID-19Last Updated:January 12, 2022Terminated
Hide Studies Not Open or Pending
Condition(s):COVID-19Last Updated:January 12, 2022Terminated
Condition(s):Atrial FibrillationLast Updated:December 30, 2015Unknown status
Condition(s):Non-valvular Atrial Fibrillation (NVAF)Last Updated:October 24, 2023Completed
Condition(s):Non-valvular Atrial Fibrillation (NVAF)Last Updated:May 30, 2019Completed
Condition(s):Atrial Fibrillation; Left Atrial Appendage Thrombosis; RivaroxabanLast Updated:March 19, 2019Unknown status
Condition(s):Venous Thromboembolism; Deep Vein Thrombosis; Pulmonary Embolism; Lower Limb Trauma; Thromboprophylaxis; ImmobilisationLast Updated:January 31, 2024Not yet recruiting
Condition(s):Atrial Fibrillation; Atrial Appendage; HemorrhageLast Updated:December 21, 2021Completed
Condition(s):Bariatric Surgery; Morbid ObesityLast Updated:July 21, 2022Completed
Condition(s):Aortic Valve Stenosis; Cardiovascular Diseases; Heart Valve Diseases; Ventricular Outflow Obstruction; ThrombosisLast Updated:January 18, 2020Completed
Condition(s):Non-Valvular Atrial FibrillationLast Updated:March 3, 2021Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.